Introduction: emerging role of epigenetic therapy: focus on decitabine - PubMed (original) (raw)
Editorial
Introduction: emerging role of epigenetic therapy: focus on decitabine
Jean-Pierre J Issa et al. Semin Hematol. 2005 Jul.
No abstract available
Similar articles
- Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
Cowan LA, Talwar S, Yang AS. Cowan LA, et al. Epigenomics. 2010 Feb;2(1):71-86. doi: 10.2217/epi.09.44. Epigenomics. 2010. PMID: 22122748 Review. - Decitabine: a historical review of the development of an epigenetic drug.
de Vos D, van Overveld W. de Vos D, et al. Ann Hematol. 2005 Dec;84 Suppl 1(Suppl 1):3-8. doi: 10.1007/s00277-005-0008-x. Ann Hematol. 2005. PMID: 16220311 Free PMC article. - Epigenetic modification boosts ovarian cancer vaccination.
Benmaamar R. Benmaamar R. Lancet Oncol. 2014 Feb;15(2):e55. Lancet Oncol. 2014. PMID: 24627909 No abstract available. - Targeting DNA methylation.
Issa JP, Kantarjian HM. Issa JP, et al. Clin Cancer Res. 2009 Jun 15;15(12):3938-46. doi: 10.1158/1078-0432.CCR-08-2783. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509174 Free PMC article. - Decitabine in acute myeloid leukemia.
Lübbert M, Minden M. Lübbert M, et al. Semin Hematol. 2005 Jul;42(3 Suppl 2):S38-42. doi: 10.1053/j.seminhematol.2005.05.007. Semin Hematol. 2005. PMID: 16015504 Review.
Cited by
- The future of epigenetic therapy in solid tumours--lessons from the past.
Azad N, Zahnow CA, Rudin CM, Baylin SB. Azad N, et al. Nat Rev Clin Oncol. 2013 May;10(5):256-66. doi: 10.1038/nrclinonc.2013.42. Epub 2013 Apr 2. Nat Rev Clin Oncol. 2013. PMID: 23546521 Free PMC article. Review. - Decitabine for the treatment of atypical chronic myeloid leukemia: A report of two cases.
Jiang H, Wu Z, Ren LI, Tao D, Tong H. Jiang H, et al. Oncol Lett. 2016 Jan;11(1):689-692. doi: 10.3892/ol.2015.3977. Epub 2015 Nov 25. Oncol Lett. 2016. PMID: 26870268 Free PMC article. - The third-time chronic myeloid leukemia in lymphoblastic crisis with ABL1 kinase mutation induced by decitabine, dexamethason combined with nilotinib and dasatinib.
Wang S, Qiao C, Zhu Y, Shen W, He G Md, Li J. Wang S, et al. J Transl Int Med. 2016 Dec 1;4(4):182-184. doi: 10.1515/jtim-2016-0039. Epub 2016 Dec 30. J Transl Int Med. 2016. PMID: 28191543 Free PMC article. - A decade of exploring the cancer epigenome - biological and translational implications.
Baylin SB, Jones PA. Baylin SB, et al. Nat Rev Cancer. 2011 Sep 23;11(10):726-34. doi: 10.1038/nrc3130. Nat Rev Cancer. 2011. PMID: 21941284 Free PMC article. Review. - [Effects of decitabine against acute T lymphoblastic leukemia cell line Molt4].
Liu J, Huang C, Cheng H, Tang G, Hu X, Zhou H, Wang J, Yang J. Liu J, et al. Zhonghua Xue Ye Xue Za Zhi. 2015 Mar;36(3):230-4. doi: 10.3760/cma.j.issn.0253-2727.2015.03.012. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 25854468 Free PMC article. Chinese.